Sign In / Sign Out
Navigation for Entire University
- ASU Home
- My ASU
- Colleges and Schools
- Map and Locations
The changing face of health care requires new, transdisciplinary models of delivery of care. Facing challenges such as skyrocketing health care costs, more people entering the system, a rise in chronic diseases, and a rapidly aging population, ASU is dedicated to changing the paradigm and directing the focus toward promoting healthy behaviors, as well as delivering health care in novel ways.
Health care is changing in many positive ways and ASU strives to be at the forefront. By embedding health promotion and disease prevention into health care, the university directly benefits the health and wellbeing of the community. Ongoing research is in areas such as lifestyle and behavior change, diabetes prevention, cardiovascular disease, adult and childhood obesity, healthy workplace environments, and nutrition and exercise science.
ASU's world-class research faculty, centers and institutes bring together thought-leaders in science, humanities, social sciences, health and engineering to spearhead new approaches to target and treat cancers, understand the spread, evolution and emergence of infectious disease, personalize medicine, and devise strategic interventions for obesity, Alzheimers and mental health challenges.
Health research in the areas of informatics and technology at ASU ranges from investigating ways to harness Big Data, to understanding the causes of Alzheimer’s disease and improving methods for predicting epileptic seizures.
The brain – and how it is used it to live life to the fullest– is at the center of ASU’s knowledge enterprise. ASU spearheads interdisciplinary work in neuroscience, psychology and the behavioral sciences.
Arizona State University is committed to finding new solutions by recognizing that major health challenges stem from many factors beyond disease itself – factors that are ecological, cultural, institutional, historical, evolutionary, social and technological. Effective, sustainable solutions to our most pressing global health challenges will need to take all of these factors into account, as well as the complex ways in which they interrelate.
Laws and related policies play a pivotal role in public health prevention efforts. Well-known examples — like vaccinations, tobacco control and food safety — reflect how laws can be used to mitigate disease and injury.
Training the health care leaders and practitioners of tomorrow, as well as fostering an environment in which new research thrives, is one of the most impactful ways ASU is shaping the future.
Transdisciplinary and life-changing work is taking place across ASU's many health related programs, departments, centers and institutes.
The mission of the National Biomarker Development Alliance (NBDA) is to address the complex and urgent challenge of creating the standards needed to support evidence-based biomarker development. The ultimate goal is to significantly advance precision (personalized) healthcare. The alliance is an independent, nonprofit organization with sponsorship from the ASU Foundation and led by Anna Barker, founding director and president of the alliance, and a professor in the School of Life Sciences at ASU. Professor Barker also serves as codirector of the Complex Adaptive Systems Initiative, an organizing construct to understand and solve multi-dimensional problems in the biological and social sciences.
Biomarkers are markers of normal or disease-related processes, or measures of response to drug therapy. They are the key to realizing a future in which patients are treated based on identifying molecular changes in their disease. These molecular profiles empower physicians to select targeted therapies, versus a "one size fits all" approach. The alliance is disease "agnostic" and was the first independent trans-sector organization to bring together key stakeholders from academia, the private sector, payers and patients/advocates to ultimately change the current dismal success rate of biomarker discovery, development and validation. The alliance is breaking new ground by establishing a network of stakeholders that integrate knowledge to successfully eliminate fragmented approaches to biomarker development.